Cas No.: | 1421502-62-6 |
Chemical Name: | (2-(6-(2-ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl)-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)(5-(piperidin-1-yl)pyrazin-2-yl)methanone |
Synonyms: | PF 06263276;PF06263276;PF 6263276 |
SMILES: | C(N1CC2NC(C3C4=C(NN=3)C=C(C3=CC(F)=C(O)C=C3CC)C=C4)=NC=2CC1)(C1=NC=C(N2CCCCC2)N=C1)=O |
Formula: | C31H31FN8O2 |
M.Wt: | 566.64 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | PF-06263276 (PF06263276, PF 6263276) is a potent, selective pan JAK inhibitor with IC50 of 2.2, 23.1, 59.9 and 29.7 nM for JAK1, JAK2, JAK3, and TYK2, respectively; demonstrates good JAK potency and kinase selectivity, exhibts inhibitory potency in human whole blood versus various stimulatory cytokines (IFNα, IL-23, IL-4, IL-6 and GM-CSF) with IC50 of 0.6-5.2 uM; suitable for inhaled and topical delivery in vivo. |